Development of anti-TNF therapy for rheumatoid arthritis.

Development of anti-TNF therapy for rheumatoid arthritis.

The aetiology of systemic, autoimmune, chronic inflammatory diseases--such as rheumatoid arthritis--is not known, and their pathogenesis is complex and multifactorial. However, progress in the characterization of intercellular mediators--proteins that are now known as cytokines--has led to the reali...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awdur:	Feldmann, M
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2002

Eitemau Tebyg

ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
gan: Feldmann, M, et al.
Cyhoeddwyd: (2011)

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
gan: Maini, R, et al.
Cyhoeddwyd: (1993)

Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis.
gan: Taylor, P, et al.
Cyhoeddwyd: (2009)

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
gan: Feldmann, M, et al.
Cyhoeddwyd: (2001)

Insights into the pathogenesis of rheumatoid arthritis from application of anti-TNF therapy.
gan: Maini, R, et al.
Cyhoeddwyd: (2000)

Targeting TNF alpha for the therapy of rheumatoid arthritis.
gan: Maini, R, et al.
Cyhoeddwyd: (1994)

Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases.
gan: Taylor, P
Cyhoeddwyd: (2001)

TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis.
gan: Maini, R, et al.
Cyhoeddwyd: (1997)

BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies.
gan: Ding, T, et al.
Cyhoeddwyd: (2010)

Anti-TNF alpha therapy in rheumatoid arthritis--current and future directions.
gan: Taylor, P, et al.
Cyhoeddwyd: (2000)

The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis.
gan: Feldmann, M, et al.
Cyhoeddwyd: (2004)

Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action.
gan: Feldmann, M, et al.
Cyhoeddwyd: (1995)

Gene expression profiling of treatment response to anti-TNF-alpha therapy in rheumatoid arthritis
gan: Meisel, C, et al.
Cyhoeddwyd: (2004)

Does bursitis of the forefoot improve in patients with rheumatoid arthritis on anti-TNF-alpha therapy?
gan: Bowen, C, et al.
Cyhoeddwyd: (2007)

Improvement in symptoms and signs in the forefoot of patients with rheumatoid arthritis treated with anti-TNF therapy.
gan: Bowen, C, et al.
Cyhoeddwyd: (2010)

Anti-TNF therapy improves hand function in rheumatoid arthritis within 3 months
gan: Hull, D, et al.
Cyhoeddwyd: (2012)

TNFα - A pivotal role in rheumatoid arthritis?
gan: Brennan, F, et al.
Cyhoeddwyd: (1992)

TNF alpha--a pivotal role in rheumatoid arthritis?
gan: Brennan, F, et al.
Cyhoeddwyd: (1992)

Anti-TNF therapy
gan: Udalova, I, et al.
Cyhoeddwyd: (2016)

The role of TNF alpha and IL-1 in rheumatoid arthritis.
gan: Feldmann, M, et al.
Cyhoeddwyd: (2001)

TNF alpha is an effective therapeutic target for rheumatoid arthritis.
gan: Feldmann, M, et al.
Cyhoeddwyd: (1995)

TNF alpha as a therapeutic target in rheumatoid arthritis.
gan: Feldmann, M, et al.
Cyhoeddwyd: (1994)

Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.
gan: Charles, P, et al.
Cyhoeddwyd: (1999)

Managing inadequate response to initial anti-TNF therapy in rheumatoid arthritis: optimising treatment outcomes
gan: Taylor, P, et al.
Cyhoeddwyd: (2022)

Gene therapy for rheumatoid arthritis?
gan: Feldmann, M
Cyhoeddwyd: (2001)

Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.
gan: Feldmann, M, et al.
Cyhoeddwyd: (1997)

Anti-cytokine therapy for rheumatoid arthritis.
gan: Maini, R, et al.
Cyhoeddwyd: (2000)

Cytokine therapy in rheumatoid arthritis.
gan: Maini, R, et al.
Cyhoeddwyd: (1996)

PREDICTING RESPONSES TO ANTI-TNF alpha THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS USING METABOLOMIC ANALYSIS OF URINE
gan: Kapoor, SR, et al.
Cyhoeddwyd: (2012)

The cytokine network in rheumatoid arthritis: definition of TNF alpha as a therapeutic target.
gan: Feldmann, M
Cyhoeddwyd: (1996)

Evaluation of TNF-alpha and IL-1 blockade in collagen-induced arthritis and comparison with combined anti-TNF-alpha/anti-CD4 therapy.
gan: Williams, R, et al.
Cyhoeddwyd: (2000)

Pain processing in rheumatoid arthritis patients successfully treated with anti-TNF medication
gan: Wordsworth, P, et al.
Cyhoeddwyd: (2009)

Clinical and experimental pain processing in rheumatoid arthritis patients treated with anti-TNF
gan: Wartolowska, K, et al.
Cyhoeddwyd: (2007)

Cerebral processing of pain in rheumatoid arthritis patients treated with antiTNF-alpha
gan: Wartolowska, K, et al.
Cyhoeddwyd: (2008)

Anti-TNFalpha therapy for rheumatoid arthritis: an update.
gan: Taylor, P
Cyhoeddwyd: (2003)

TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases
gan: Feldmann, M, et al.
Cyhoeddwyd: (2003)

Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease.
gan: Maini, R, et al.
Cyhoeddwyd: (1995)

The value of a biologics clinic: Adherence to the BSR guidelines for the use of anti-TNF alpha therapy in rheumatoid arthritis
gan: MacDougall-Davis, S, et al.
Cyhoeddwyd: (2008)

TNFα blockade in rheumatoid arthritis: Rationale, clinical outcomes and mechanisms of action
gan: Elliott, M, et al.
Cyhoeddwyd: (1995)

TNF alpha blockade in rheumatoid arthritis: rationale, clinical outcomes and mechanisms of action.
gan: Elliott, M, et al.
Cyhoeddwyd: (1995)